Revivo Therapeutics
Clinical stage biotechnology company developing a new class of cognitive enhancing small molecules targeting cognitive decline. Our first drug candidate RIV-5061 targets the treatment of Mild Cognitive Impariment. We are in the process of raising funding for Phase 1/1b clinical trials.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Revivo Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
- JH
Jack Harley
Operations Analyst · Other
EmailPhone
Showing 1 of 2 verified contacts
Top roles at Revivo Therapeutics
2 distinct titles indexed · top 2 shown.
- 1operations analyst
- 1strategic advisor
Sign up to unlock all 2 contacts at Revivo Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Revivo Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.